Cell cycle regulation of PML modification and ND10 composition
about
PML nuclear bodiesThe bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription.Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infectionsInteraction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption.The mechanisms of PML-nuclear body formationSUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavageThe infected cell protein 0 encoded by bovine herpesvirus 1 (bICP0) associates with interferon regulatory factor 7 and consequently inhibits beta interferon promoter activityAbility of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cellsPIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodiesOverexpression of the human MNB/DYRK1A gene induces formation of multinucleate cells through overduplication of the centrosomeBovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting ApoptosisConcepts of papillomavirus entry into host cellsThe potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1The SUMO-specific protease SENP5 is required for cell division.DAXX interacts with heat shock factor 1 during stress activation and enhances its transcriptional activityRole of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradationTelomeric DNA mediates de novo PML body formationND10 components relocate to sites associated with herpes simplex virus type 1 nucleoprotein complexes during virus infection.Nuclear aggresomes form by fusion of PML-associated aggregates.Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis.Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome.Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection.A role for cytoplasmic PML in cellular resistance to viral infectionEpstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.Towards an understanding of the herpes simplex virus type 1 latency-reactivation cyclePrediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsPhosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1.SUMO-1 modification of human cytomegalovirus IE1/IE72Effects of promyelocytic leukemia protein on virus-host balance.Cellular stress rather than stage of the cell cycle enhances the replication and plating efficiencies of herpes simplex virus type 1 ICP0- virusesThe herpes simplex virus immediate-early ubiquitin ligase ICP0 induces degradation of the ICP0 repressor protein E2FBP1.Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressorPolo-like kinase 1-mediated phosphorylation of Forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function.Barrier to auto integration factor becomes dephosphorylated during HSV-1 Infection and Can Act as a host defense by impairing viral DNA replication and gene expressionDual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes.Cytoplasmic localized infected cell protein 0 (bICP0) encoded by bovine herpesvirus 1 inhibits β interferon promoter activity and reduces IRF3 (interferon response factor 3) protein levels.Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formationHypophosphorylated SR splicing factors transiently localize around active nucleolar organizing regions in telophase daughter nuclei.Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
P2860
Q22065791-A48DE74B-1862-48FD-99C5-0CB2282CF185Q24291697-642D96BD-1173-47FC-8DF8-17E82A2C4903Q24297146-0B5BB389-8453-42E5-A9D5-3169DAA349E5Q24298226-656AAD2F-2DC4-4F8D-8B63-A14CD3370337Q24305676-119BEC55-B806-4048-B783-72EE8F96C512Q24311595-88EEFE4F-EA29-497B-B08A-E3A7B43CBCB5Q24320238-F71E65DA-62DC-4EA2-BAE2-720614EE091AQ24322885-4D0EC716-B006-4BCD-ADF7-D4307EFEFEE1Q24563268-84FA6984-651C-4B26-B5DC-7E5D88B427D4Q24599898-D53C5B20-13BA-4B58-BBBD-809A6DA6ECEFQ24803124-A599AD2A-63B7-445F-9A0E-3C14084F2A5FQ26864175-39231191-65AD-4D1E-8E71-8DC81FAF221BQ27026900-4A95EEF3-794B-4EF8-BB1B-E10DADA30C0BQ27027918-B6DBB3B2-66E2-480F-99F7-33FF2ED51947Q27863924-E763621A-9255-4117-A7FA-2C09E27C3BF2Q28114898-258EA374-4AC8-464E-8141-5E7338DC67E7Q28367104-7B880983-955A-42DB-B648-53E4E5F77C56Q28508824-66184E9E-B6EB-43FF-B653-59870E93812EQ30475799-E18F1848-F3F6-4704-A7F9-485601C75844Q30476220-EB0263CA-C55D-4DAC-AE9C-9A854ABC3B33Q30482510-54C58B3B-23C0-4FFC-B16A-64B2F1B215E3Q30703512-3AD15AC3-8BB4-425E-AED2-345511AF3D92Q30834143-28F6D013-B944-41D1-B829-6375EE301796Q33338503-FC36724F-5BB9-419F-A0CA-13E8598B67D4Q33373662-74D531ED-04EC-447D-AA50-34AFBD530DFFQ33654414-9B9254EC-67BF-47E8-B4EA-9F75210A43A0Q33755486-CBAA06AF-ACF7-43A8-B2E5-0ABE53994BFCQ33877041-E05F93B8-CF60-407B-9805-AFB08720234CQ34332305-53F4A8B4-D930-4362-B108-09E8A525367FQ34335521-4FABBE05-8ADB-47DE-A530-03B333A16989Q34647412-B991989E-C470-4721-A289-6067C16C78BDQ34742340-D4D98384-9C8C-4E76-98C8-2683EA3705C4Q34868294-95647DE7-A2BA-4759-8608-1D29C49FBA5AQ35055612-215517A4-DAC6-491D-B6DB-44D3C12D1C1BQ35191248-4A1EC969-A601-476D-A75B-351637C572AFQ35562632-B00CCFF5-3AE0-49C3-B2E6-80A9036DB283Q36142258-5CF48212-B813-4C43-A94A-76F5C0CC60CAQ36216480-3A9D33B7-8A85-418A-9136-FE2D94BB3DFEQ36322671-ED7F01E4-BB0D-4871-B871-B07BD45C98C6Q36421322-5BF18F58-0DEC-4870-A508-5C7B04F55674
P2860
Cell cycle regulation of PML modification and ND10 composition
description
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/12/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/12/01)
@nl
наукова стаття, опублікована в грудні 1999
@uk
مقالة علمية (نشرت في ديسمبر 1999)
@ar
name
Cell cycle regulation of PML modification and ND10 composition
@ast
Cell cycle regulation of PML modification and ND10 composition
@en
Cell cycle regulation of PML modification and ND10 composition
@nl
type
label
Cell cycle regulation of PML modification and ND10 composition
@ast
Cell cycle regulation of PML modification and ND10 composition
@en
Cell cycle regulation of PML modification and ND10 composition
@nl
prefLabel
Cell cycle regulation of PML modification and ND10 composition
@ast
Cell cycle regulation of PML modification and ND10 composition
@en
Cell cycle regulation of PML modification and ND10 composition
@nl
P2093
P1476
Cell cycle regulation of PML modification and ND10 composition
@en
P2093
P304
P407
P478
112 ( Pt 24)
P577
1999-12-01T00:00:00Z